Andrea Seat, DPM
Podiatrist · Oklahoma City, OKNPI 1326420332
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (50.0%), travel and lodging and education — rather than concentrated in one kind of arrangement. Stryker accounts for 65.0% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $3,430 and has fallen 84.1% since, to $544 in 2025.
Across 79 payments — averaging $64.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$3K
- Pylant Medical$1K
- Angiodynamics, Inc.$147
- Smith+Nephew$128
- Organogenesis Inc.$108
- Medtronic$43
- plus $165 from 7 others
What the payments were for
- Travel & lodging$1,33226%
- Food & beverage$2,55550%
- Education$1,22624%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 49 | $3,323 |
| Pylant Medical | 3 | $1,198 |
| Angiodynamics, Inc. | 1 | $147 |
| Smith+Nephew | 9 | $128 |
| Organogenesis Inc. | 6 | $108 |
| Medtronic | 2 | $43 |
| Johnson & Johnson | 2 | $32 |
| Medline Industries LP | 2 | $30 |
| Kerecis Limited | 1 | $29 |
| Nevro Corp. | 1 | $27 |
| Melinta Therapeutics, LLC | 1 | $20 |
| Bioventus LLC | 1 | $14 |
| Orthofix Medical, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ALLOWRAP$904
- VARIAX$538
- PROSTEP MICA$281
- INFINITY ADAPTIS$153
- Auryon Laser System 100-120 Vac$147
- BIO4$142
How this compares
$5,113 in reported general payments places this provider in the 75th percentile of 54 podiatrist providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 26 | $621 |
| Methylprednisolone | 46 | $292 |
| Doxycycline Hyclate | 19 | $178 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $150 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Oklahoma City
- David CavallaroOklahoma City$22K
- Patricia BoehleOklahoma City$10K
- Angela SchuffOklahoma City$4K
- James FlynnOklahoma City$4K
- Terry NayfaOklahoma City$3K
- Kenneth GoldaOklahoma City$2K
- David WadeOklahoma City$2K
- Wolfgang KienzleOklahoma City$2K
- David leOklahoma City$1K
- Benjamin HarkessOklahoma City$955
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.